Skip to main content

Table 2 Prognostic factors for overall survival of patients with gastric cancer

From: Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer

Parameter

Univariate survival analysis

 

Multivariate survival analysis

HR

95%CI

p

 

HR

95%CI

p

Age at diagnosis

 

 < 60

1.000

      

 ≥ 60

1.628

0.878–3.021

0.122

    

Gender

 

 Male

1.000

      

 Female

1.116

0.571–2.181

0.748

    

Tumor size (cm)

 

 < 5

1.000

      

 ≥ 5

1.298

0.706–2.387

0.748

    

Histologic type

 

 Adenocarcinoma

1.000

      

 Signet ring cell carcinoma

1.441

0.348–5.969

0.614

    

Degree of differentiation

 

 Medium-low/Medium/High

1.000

      

 Low

1.167

0.637–2.140

0.617

    

Location

 

 Other locations

1.000

      

 Middle third

2.179

1.109–4.281

0.024

 

2.723

1.334–5.520

0.005

Depth of invasion

 

 T1/T2

1.000

      

 T3/T4

3.705

1.142–12.017

0.029

 

3.357

1.007–11.186

0.049

Lymph node status

 

 N0/N1/N2

1.000

      

 N3

5.676

2.953–10.910

< 0.001

 

5.287

2.723–10.265

< 0.001

Distant metastasis

 

 M0

1.000

      

 M1

3.305

1.001–10.914

0.049

    

TNM stage

 

 Stage I/II

1.000

      

 Stage III/IV

4.214

1.651–10.751

0.003

    
  1. HR, Hazard ratio; 95%CI, 95% confidence interval